Idiosyncratic Drug-Induced Liver Injury Is Associated With Substantial Morbidity and Mortality Within 6 Months From Onset
Robert J. Fontana, Paul Hideyo Hayashi, Jiezhun Gu et al. · Gastroenterology · 2014
Cited by 244 works. doi:10.1053/j.gastro.2014.03.045 Open-access PDF
Authors
- Robert J. Fontana
- Paul Hideyo Hayashi
- Jiezhun Gu
- K. Rajender Reddy
- Huiman Xie Barnhart
- Paul Brent Watkins
- José Serrano
- William M. Lee
- Naga Chalasani
- Andrew Stolz
- Timothy J. Davern
- Jayant A. Talwakar
References
- Results of a Prospective Study of Acute Liver Failure at 17 Tertiary Care Centers in the United States
- The model for end-stage liver disease (MELD)
- Drug-Induced Liver Injury: An Analysis of 461 Incidences Submitted to the Spanish Registry Over a 10-Year Period
- Causes, Clinical Features, and Outcomes From a Prospective Study of Drug-Induced Liver Injury in the United States
- Incidence of drug-induced hepatic injuries: A French population-based study
- Outcome and prognostic markers in severe drug‐induced liver disease†
- Nonalcoholic fatty liver disease in patients with type 2 diabetes
- Drug-Induced Liver Injury Network (DILIN) Prospective Study
- Liver transplantation for acute liver failure from drug induced liver injury in the United States
- Drug-Induced Acute Liver Failure